Presentation is loading. Please wait.

Presentation is loading. Please wait.

Roadmap to Active Healing

Similar presentations


Presentation on theme: "Roadmap to Active Healing"— Presentation transcript:

1 Roadmap to Active Healing

2 Indications* The EXOGEN® Ultrasound Bone Healing System, is indicated for the non-invasive treatment of established non-unions† excluding skull and vertebra. In addition, EXOGEN is indicated for accelerating the time to a healed fracture for fresh, closed, posteriorly displaced distal radius fractures and fresh, closed or Grade I open tibial diaphysis fractures in skeletally mature individuals when these fractures are orthopedically managed by closed reduction and cast immobilization. There are no known contraindications for the EXOGEN device. Safety and effectiveness has not been established for individuals lacking skeletal maturity; pregnant or nursing women; patients with cardiac pacemakers; on fractures due to bone cancer; or on patients with poor blood circulation or clotting problems. Some patients may be sensitive to the ultrasound gel. A non-union is considered to be established when the fracture site shows no visibly progressive signs of healing EXOGEN is a registered trademark of Bioventus LLC Although you will often see similar language from our indication within medical policies, Medical Policies can and often will differ from our indications Work with your PR&R team to help maximize these indications

3 Customers Categories Each territory has on average 30+ dabblers.
Title Description Usage Number EXOGEN Users Use EXOGEN regularly and appropriately 2.5 units/month 350 EXOGEN Dabblers Use EXOGEN as their BGS of choice, but only as for “last resort” cases 1 unit/2 months 7,800 Spreaders Use whatever BGS is available. They are all the same Variable 9,300 E-Stim users Use only E-stim. 8,000 Non BGS users Haven’t prescribed in last 2 years. Zero 3,900 Each territory has on average 30+ dabblers. Each dabbler converted to a “user” is worth $60k per year Potential is therefore $1.8m per rep or $450m nationally How can you use EXOGEN science to realize some of this potential?

4 But….Don’t Forget The Spreaders
You have the key messages and tools with which to convince them: Unique Technology 86% non-union heal rate1 Only product approved to accelerate the healing of indicated* fresh fractures Only 20 minutes per day Peer to peer dialog is key Ideal targets for Science Summits and/or local surgeon speaker meetings Nolte PA, van der Krans A, Patka P, Janssen IM, Ryaby JP, Albers GH. “Low-intensity pulsed ultrasound in the treatment of nonunions.” J Trauma. 2001;51(4):

5 EXOGEN Dabblers

6 Assumptions You know your key clinical information
Heckman, Kristiansen, Nolte, Gebauer, Cook.. You know where to find scientific information MOA brochure, Exopedia, sales sheets…. You know the support you have in addition Science summits, local meetings (surgeon speakers or Chris) You are not totally comfortable with when and how to use the science and when to use the additional support

7 Process Meeting Run through key science papers Discuss when to use
Demonstrate how to use Provide a Roadmap to guide you Role play at District Breakout meeting Post Meeting Provide a new White Paper (coming soon) which contains and explains the new (and old) evidence Reps – Identify Dabbler physicians Reps/DOSs – Target strategic physicians Use provided information Use additional resources – Scientific liaison, Science Summits, Regional speakers

8 Assumptions You have convinced them sufficiently that when they decide they need a bone stimulator they turn to EXOGEN They don’t understand the product well enough for EXOGEN to be front of mind when planning treatment Surgery is the main consideration Biologics mean bone graft, growth factor, stem cell, etc.

9 Dabblers Roadmap to Becoming Users
Risk Factors Age Diabetes Smoking Osteoporosis Non-Unions Hypertrophic Atrophic

10 Lifestyle (e.g. smoking) Medications Fracture Factors:
(Surgical) Technique Patient Factors: Comorbidities Lifestyle (e.g. smoking) Medications Fracture Factors: Bone and location Fracture type and severity Soft tissue damage Patient Fracture (Surgical) Technique: Reduction Stabilization Gap filling Soft tissue repair Not Healed Healed

11 Often Sufficient Not Healed Healed Fracture Patient
(Surgical) Technique Not Healed Healed

12 Patient factors can’t be addressed by surgery alone
Sometimes Not Enough Fracture too severe Patient factors can’t be addressed by surgery alone Risk Factors Lead to: Delayed Union Non-Union Fracture Patient (Surgical) Technique Not Healed Healed

13 Active Healing Technology
Fracture Add something to help: Bone graft Growth Factor Stimulation Patient Active Healing Technology (Surgical) Technique Not Healed Healed

14 May Help Tip the Balance
Fracture EXOGEN May Help Tip the Balance Patient EXOGEN (Surgical) Technique Not Healed Healed

15 Risk Factors

16 Question Which of these risk factors is most commonly thought of as a reason to use bone growth stimulation? Osteoporosis Smoking Advanced age Diabetes

17 Surgeon view on factors impacting the decision to use a bone healing adjunct
Points allocated Q19. Think of the characteristics of all of your fracture patients. Then, please allocate 100 points across the listed characteristics based on their importance in your decision to treat with non-invasive bone stimulation. The more points you allocate, the more important that characteristic is to you. DOF

18 Many of these are patient factors (green) not fracture factors (orange)
The remainder are the key fracture factors for which an adjunct to surgery may be required Points allocated Q19. Think of the characteristics of all of your fracture patients. Then, please allocate 100 points across the listed characteristics based on their importance in your decision to treat with non-invasive bone stimulation. The more points you allocate, the more important that characteristic is to you. DOF

19 Risk Factors Age Diabetes Smoking Osteoporosis

20 Question Which of these molecules is an (upstream) signaling molecule that can lead to up-regulation of the others? Alkaline Phosphatase COX2 VEGF BMP2

21 Age – The Problem Clinical & Pre-Clinical *
Increasing age is a risk factor for fracture union1,2 Older animals produce less COX23 Reduced COX-2 expression in aged mice is associated with impaired fracture healing as seen with reductions in mineral and vascular volume at the fracture site3 * p < 0.02 The risk for impaired fracture healing also increases as people age. Studies show that people as young as 30 years of age have diminished bone healing capacity. More than half of the US population is this age or older. Advanced age reduces the number of bone marrow stem cells and inhibits vascularization at bone healing sites. The effect of advanced age was one of the endpoints in a prospective, randomized, placebo-controlled, double-blind, multicenter, level I study of 33 fractures treated with LIPUS and 34 fractures treated with a placebo device. Patients had an acute closed or Grade I open tibial diaphyseal fracture that was primarily transverse, short oblique, or short spiral and that could be treated effectively with closed reduction and immobilization in a cast. The graph shows that LIPUS accelerates healing of indicated fresh fractures in younger and older patients. In older patients, LIPUS accelerated healing by more than 10 weeks. What could your older patients do with an extra 10 weeks of a healed fresh fracture? mRNA levels of COX2 in young (Open bars) and old (Filled bars) in mice * p < 1. Heckman et al Journal of Bone and Joint Surgery 76A:26–34. 2. Heckman and Sarasohn-Kahn Bulletin Hospital Joint Diseases 56(1):63–72. 3. Naik et al., J Bone Miner Res Feb;24(2):251-64 21

22 Age – The EXOGEN Effect Clinical * ***
p < 0.02 *** p < LIPUS Placebo 84 days 103 days (n=21) (n=12) (n=18) (n=15) 126 days 187 days 42 days 33% Acceleration 45% Acceleration >30 The risk for impaired fracture healing also increases as people age. Studies show that people as young as 30 years of age have diminished bone healing capacity. More than half of the US population is this age or older. Advanced age reduces the number of bone marrow stem cells and inhibits vascularization at bone healing sites. The effect of advanced age was one of the endpoints in a prospective, randomized, placebo-controlled, double-blind, multicenter, level I study of 33 fractures treated with LIPUS and 34 fractures treated with a placebo device. Patients had an acute closed or Grade I open tibial diaphyseal fracture that was primarily transverse, short oblique, or short spiral and that could be treated effectively with closed reduction and immobilization in a cast. The graph shows that LIPUS accelerates healing of indicated fresh fractures in younger and older patients. In older patients, LIPUS accelerated healing by more than 10 weeks. What could your older patients do with an extra 10 weeks of a healed fresh fracture? Older patients are at increased risk of delayed fracture healing EXOGEN lessened the effect of this risk Heckman et al Journal of Bone and Joint Surgery 76A:26–34. Heckman and Sarasohn-Kahn Bulletin Hospital Joint Diseases 56(1):63–72. 22

23 Age – The EXOGEN Effect In Vivo Day Day 10 10 14 21 21 28
8 week old mice 40 week old mice 40 week old mice with EXOGEN Older animals are at increased risk of delayed fracture healing EXOGEN lessened the effect of this risk Radiographs of 8 week old mice were taken in situ, while the radiographs of the 40 week old mice were taken after excision. Therefore the internal fixation has been removed in the older mice Katano et al., Exp Anim. 2011;60(4):385-95

24 The EXOGEN Effect – A Possible Explanation
In Vitro The EXOGEN Effect – A Possible Explanation EXOGEN increased COX2 production in osteoblasts, a key fracture healing factor that is compromised in older animals Tang Mol Pharmacol Jun;69(6):

25 Age – Summary Age is associated with slower healing
EXOGEN has been shown, in-vivo and clinically, to reduce this effect Age is related to lower COX-2 production, a factor which EXOGEN has been shown to upregulate EXOGEN treatment lessened the effect of age on healing possibly through counteracting reduced COX2 expression

26 Diabetes – The Problem Patients with diabetes mellitus (DM) have many problems healing tissues including fracture One factor linked to healing problems in diabetics is vascular insufficiency

27 Diabetes – The EXOGEN Effect
Clinical Diabetes – The EXOGEN Effect Post marketing data on non-union fractures In patients with diabetes the heal rate was 84.2% (n=181/215) compared to 84.4% (n=3,141/3,722) for all fractures DOF

28 Question What is angiogenesis?
The ability of cells to migrate to the fracture The formation of new blood vessels The formation of bone without cartilage The process how bone remodels

29 The EXOGEN Effect – A Possible Explanation
In Vivo The EXOGEN Effect – A Possible Explanation * Day 7 E = EXOGEN Control VEGF VEGF-mediated angiogenesis on the chicken chorioallantoic membrane EXOGEN increased VEGF protein expression in diabetic animals VEGF is a potent angiogenic (new blood vessel formation) factor Coords et al., J Orthop Res Feb;29(2):181-8 Ehrbar et al., Circ Res. 2004;94:

30 The EXOGEN Effect – A Possible Explanation
In Vivo The EXOGEN Effect – A Possible Explanation Diabetic animals have compromised vascularity EXOGEN restored levels to those of non diabetic animals * New blood vessel production in response to EXOGEN (w/US) using PECAM (CD-31) to assess day 10 neovascularisation Coords et al., J Orthop Res Feb;29(2):181-8

31 Diabetes – Summary Diabetes mellitus patients are at risk of fracture healing problems potentially linked to compromised vascularity The EXOGEN effect in non-union patients was comparable to the overall population EXOGEN increases growth factors associated with new blood vessel formation, and with blood vessel formation itself For patients with diabetes there was no significant change in the efficacy of EXOGEN possibly through increasing VEGF levels and vascularity

32 Question Which of these effects of smoking is most implicated in poor healing? Cancer risk Compromised blood supply Reduced lung function Coronary heart disease risk

33 Smoking – The Problem Smoking is a known risk factor in fracture healing 1 Cigarette smoking diminishes vascularization at bone healing sites through the action of nicotine 2 1.Bishop J Am Acad Orthop Surg May;20(5):273-82 2. Ueng J. Trauma (4)

34 Smoking – The EXOGEN Effect
Clinical Smoking – The EXOGEN Effect Cook et al. 41% reduction in healing time for smokers with tibial fractures 51% reduction in healing time for smokers with distal radius fractures Post marketing data on non-union fractures In patients who were currently smoking, the heal rate was 81.3% (n=615/756) compared to 84.4% (n=3,141/3,722) for all fractures Cook et al Clin Orthop Relat Res Apr;(337): DOF

35 The EXOGEN Effect – A Possible Explanation
In Vivo The EXOGEN Effect – A Possible Explanation mRNA levels Control VEGF VEGF-mediated angiogenesis on the chicken chorioallantoic membrane EXOGEN increased VEGF signaling at the mRNA level VEGF is a potent angiogenic (new blood vessel formation) factor Naruse et al., Ultrasound Med Biol Jul;36(7): Ehrbar et al., Circ Res. 2004;94:

36 Smoking – Summary Smoking is a known risk factor in fracture healing linked to diminished vascularization which delays mineralisation EXOGEN lessened this risk in fresh fractures and the effect in non-union patients was comparable to the overall population EXOGEN increases growth factors associated with new blood vessel formation EXOGEN accelerated healing in patients who smoke possibly through increasing VEGF expression and vascularity

37 Osteoporosis – The Problem
Osteoporosis is a metabolic condition where sufferers have lower bone mineral density than normal and are more likely to fracture Osteoporotic fracture healing is a problem due to difficulties of achieving fixation into poor quality bone stock

38 Osteoporosis – The EXOGEN Effect
Clinical Osteoporosis – The EXOGEN Effect The post marketing data on non-union fractures showed that in patients who suffered from osteoporosis the heal rate was 91.7% (n=55/60) compared to 84.4% (n=3,141/3,722) for all fractures DOF

39 The EXOGEN Effect – A Possible Explanation
In Vivo The EXOGEN Effect – A Possible Explanation This paper used a model of osteoporotic fracture repair to assess the effect of EXOGEN on fracture repair The paper showed how a number of growth factors are up-regulated by EXOGEN (BMP2 & VEGF). Fractures treated with EXOGEN had greater callus formation and enhanced endochondral ossification. Cheung J Orthop Res Jan;30(1):129-36

40 Question What is endochondral ossification?
Something geeky scientists refer to Formation of Bone within cartilage Formation of Bone without cartilage A process that produces BMPs

41 Osteoporosis – Summary
Osteoporosis is a potential risk factor for compromised fracture healing due to poor quality bone stock The EXOGEN effect in non-union patients was comparable to the overall population EXOGEN upregulated key growth factors and enhanced endochondral ossification and callus formation EXOGEN has been shown to resolve osteoporotic non-unions possibly through enhanced growth factor expression and callus formation

42 Hypertrophic Non-Unions

43 Question What does hypertrophic mean? Too much movement Over sensitive
Above the fracture line Enlarged

44 Hypertrophic Non-Unions – The Problem
Hypertrophic non-unions are thought to be caused by excessive motion at the fracture site However, if the fracture is grossly stable, then all that is needed is to enhance the callus to mineralize through endochondral ossification

45 Hypertrophic Non-Unions – The EXOGEN Effect
Clinical Hypertrophic Non-Unions – The EXOGEN Effect Nolte 80% (n=10/12) of established hypertrophic non-unions healed successfully with only the addition of 20mins. per day of EXOGEN treatment Gebauer 100% (n=11/11) of established hypertrophic non-unions healed successfully with only the addition of 20mins. per day of EXOGEN treatment Package Insert Summary of non-union clinical data Nolte et al., J Trauma Oct;51(4): Gebauer et al., Ultrasound Med Biol Oct;31(10):

46 Hypertrophic Non-Unions – The EXOGEN Effect
Clinical Hypertrophic Non-Unions – The EXOGEN Effect German study of delayed unions (> 16 weeks) Key findings: Bone mineral density was significantly improved (p=0.002) in the fracture gap of EXOGEN treated patients A significant mean reduction in bone gap area also favored EXOGEN treatment Mineralization at the fracture site was increased Schofer et al., BMC 8;11:

47 The EXOGEN Effect – A Possible Explanation
In Vitro The EXOGEN Effect – A Possible Explanation EXOGEN EXOGEN significantly increased alkaline phosphatase (p < 0.04) a marker of bone formation The formation of calcium nodules was significantly greater (p < 0.001) with EXOGEN treatment EXOGEN positively impacted mineralization of relevant cells CONTROL A&B - human osteoblasts stained with alizarin red to demonstrate calcium formation Lower panel shows image analysis of representative cultures (* p < 0.001) Leung et al., Clin Orthop Relat Res. 2004;(418):253-9.

48 Hypertrophic Non-Unions - Summary
Grossly stable hypertrophic non-unions may be resolved via enhanced mineralization Clinical data shows resolution with EXOGEN alone and increased mineral content at the fracture site Both markers of bone formation and mineral content have been demonstrated to be positively impacted with EXOGEN EXOGEN has been shown to resolve hypertrophic non-unions possibly through enhanced callus formation

49 Atrophic Non-Unions

50 Atrophic Non-Unions – The Problem
Healing has stopped, probably due to some aspect of the patients biology The fracture gap still exists on X-Ray and the ends of the bone may become sclerotic (thickened) and/or avascular (“dead”) A surgical option is to remove this bone, find bleeding bone and then re-unite the ends.

51 Atrophic Non-Unions – The EXOGEN Effect
Clinical Atrophic Non-Unions – The EXOGEN Effect Nolte 80% (n=4/5) of established atrophic non-unions healed successfully with only the addition of 20 mins. per day of EXOGEN treatment Gebauer 86% (n=30/35) of established atrophic non-unions healed successfully with only the addition of 20 mins. per day of EXOGEN treatment Package Insert Summary of non-union clinical data Nolte et al., J Trauma Oct;51(4): Gebauer et al., Ultrasound Med Biol Oct;31(10):

52 Question What cell removes / resorbs bone? Osteoblast Osteoclast
Osteocyte Pericyte

53 The EXOGEN Effect – A Possible Explanation
In Vivo The EXOGEN Effect – A Possible Explanation This paper showed that bone can be resorbed biologically by osteoclasts and then remodelled EXOGEN enhanced bone removal at the fracture site and this was linked to more osteoclasts EXOGEN caused improved bone remodelling Control EXOGEN Freeman J Orthop Res May;27(5):673-9.

54 The EXOGEN Effect – A Possible Explanation
In Vivo The EXOGEN Effect – A Possible Explanation mRNA levels Control VEGF VEGF-mediated angiogenesis on the chicken chorioallantoic membrane EXOGEN increased VEGF signaling at the mRNA level VEGF is a potent angiogenic (new blood vessel formation) factor Naruse et al., Ultrasound Med Biol Jul;36(7): Ehrbar et al., Circ Res. 2004;94:

55 Atrophic Non-Unions – Summary
These are characterised by thick and/or dead bone Clinical data showed that EXOGEN alone resolved these EXOGEN enhanced bone resorption and increased vascularity necessary to re-initiate healing EXOGEN has been shown to resolve atrophic non-unions possibly through enhanced bone resorption and vascularity

56 Follow Up

57 EXOGEN Dabblers – Follow Up
Understanding our data and how it applies to fracture healing is one of the keys for this group of people. Identify these people Use the roadmaps to guide your discussions and provide useful leave behinds They are ideal targets for Chris to follow up with and engage in a dialogue about how the clinical and basic science might inform their treatment considerations Face to face meetings Tel-con/Video con to address specific questions Meet at trade-shows Follow-up at science summits

58 Papers

59 Therefore, EXOGEN increased mineralization at the fracture site
Clinical Delayed union RCT (> 16 weeks) (Delayed union has a non-union definition) Key EXOGEN findings: Significant increase in bone mineral density in the fracture gap (p = 0.002) Significantly smaller fracture gap area (p = 0.014) Therefore, EXOGEN increased mineralization at the fracture site Schofer et al., BMC 8;11:

60 In Vitro In vitro study (Cells) of human periosteal cells
Key EXOGEN findings: Significant increase in VEGF expression (p < 0.03) Significantly increased mineralization (p < 0.001) Therefore, EXOGEN increased factors and enhanced processes important for fracture healing in an animal model Leung et al., Clin Orthop Relat Res. 2004;(418):253-9.

61 In Vitro In vitro study (Cells) Key EXOGEN findings:
Integrin is essential for transducing the signal into the cell Significantly increased COX2 and PGE2 production (p ≤ 0.05) Significantly increased mineralization (p < 0.05) Therefore, EXOGEN worked through a well defined pathway to increase mineralization Tang Mol Pharmacol Jun;69(6): Tang et al.,Mol Pharmacol 69:2047–2057, 2006

62 Enhanced bone removal at the facture site
In Vivo In vivo (animal) study Key EXOGEN findings: Significantly increased number of osteoclasts in early and middle weeks (p < 0.05) Enhanced bone removal at the facture site Therefore, EXOGEN caused the biological removal of bone in an animal model Freeman J Orthop Res May;27(5):673-9.

63 In Vivo In vivo (animal) study of healing of old and young animals
Key EXOGEN findings: Accelerated healing response in old animals compared to young animals Therefore, EXOGEN lessened the effect of age on healing time in an animal model Katano et al., Exp Anim. 2011;60(4):385-95

64 In Vivo In vivo (animal) study Key EXOGEN findings:
Many growth factors were increased at the fracture site These include VEGF and BMP’s Therefore, EXOGEN increased factors required for fracture healing in an animal model Naruse et al., Ultrasound Med Biol Jul;36(7):

65 In Vivo In vivo (animal) study of Type I diabetes Key EXOGEN findings:
Reversed deficits in VEGF production Significantly increased the number of blood vessels (p < 0.017) Therefore, EXOGEN mitigated the effects of diabetes on fracture healing in an animal model Coords et al., J Orthop Res Feb;29(2):181-8

66 Clinical Cost analysis of Heckman JBJS study (1994) Key EXOGEN findings: Significantly improved fracture healing in all patients studied (p = ) Maximum benefit in the over 30 group that otherwise healed more slowly Therefore, EXOGEN lessened age-related delays in healing Heckman Bull Hosp Jt Dis. 1997;56(1):63-72

67 In Vivo In Vivo (animal) study of osteoporotic fracture healing Key EXOGEN findings: Increased BMP2 and VEGF Greater callus formation and enhanced endochondral ossification Therefore, EXOGEN enhanced osteoporotic fracture repair in an animal model Cheung J Orthop Res Jan;30(1):129-36


Download ppt "Roadmap to Active Healing"

Similar presentations


Ads by Google